Zobrazeno 1 - 10
of 830
pro vyhledávání: '"Urosevic J"'
Autor:
Smith JM; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Barlaam B; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Beattie D; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Bradshaw L; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Chan HM; Research and Early Development, Oncology R&D, AstraZeneca, Waltham 02451, United States., Chiarparin E; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Collingwood O; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Cooke SL; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Cronin A; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Cumming I; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Dean E; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Debreczeni JÉ; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Del Barco Barrantes I; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Diene C; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Gianni D; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Guerot C; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Guo X; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Guven S; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Hayhow TG; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Hong T; Research and Early Development, Oncology R&D, AstraZeneca, Waltham 02451, United States., Kemmitt PD; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Lamont GM; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Lamont S; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Lynch JT; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., McWilliams L; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Moore S; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Raubo P; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Robb GR; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Robinson J; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Scott JS; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Srinivasan B; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Steward O; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Stubbs CJ; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Syson K; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Tan L; Pharmaron Beijing Company, Ltd., Beijing 100176, P. R. China., Turner O; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Underwood E; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Urosevic J; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Vazquez-Chantada M; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Whittaker AL; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Wilson DM; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Winter-Holt JJ; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2024 Aug 22; Vol. 67 (16), pp. 13604-13638. Date of Electronic Publication: 2024 Jul 30.
Autor:
Martinovski, Vladimir
Texte remanié de: Thèse de doctorat--Littérature générale et comparée--Paris 3, 2007. Titre de soutenance : Aspects de la poésie ekphrastique : C. Baudelaire, "les Fleurs du mal", W. C. Williams, "Tableaux d'après Bruegel", S. Janevsk
Externí odkaz:
http://catalogue.bnf.fr/ark:/12148/cb41468078d
Autor:
Vasalou C; Clinical Pharmacology & Safety Sciences, Waltham, Massachusetts, USA., Proia TA; Translational Medicine, Waltham, Massachusetts, USA., Kazlauskas L; AstraZeneca Research & Development, Waltham, Massachusetts, USA., Przybyla A; AstraZeneca Research & Development, Waltham, Massachusetts, USA., Sung M; AstraZeneca Research & Development, Waltham, Massachusetts, USA., Mamidi S; AstraZeneca Research & Development, Cambridge, UK., Maratea K; Clinical Pharmacology & Safety Sciences, Waltham, Massachusetts, USA., Griffin M; Clinical Pharmacology & Safety Sciences, Waltham, Massachusetts, USA., Sargeant R; Clinical Pharmacology & Safety Sciences, Cambridge, UK., Urosevic J; AstraZeneca Research & Development, Cambridge, UK., Rosenbaum AI; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, South San Francisco, California, USA., Yuan J; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, South San Francisco, California, USA., Aluri KC; AstraZeneca Research & Development, Waltham, Massachusetts, USA., Ramsden D; AstraZeneca Research & Development, Waltham, Massachusetts, USA., Hariparsad N; AstraZeneca Research & Development, Waltham, Massachusetts, USA., Jones RDO; AstraZeneca Research & Development, Cambridge, UK., Mettetal JT; AstraZeneca Research & Development, Waltham, Massachusetts, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Jun; Vol. 13 (6), pp. 994-1005. Date of Electronic Publication: 2024 Mar 26.
Autor:
Lawson M; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Cureton N; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Ros S; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Cheraghchi-Bashi A; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Urosevic J; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., D'Arcy S; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Delpuech O; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., DuPont M; Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Fisher DI; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Gangl ET; Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Lewis H; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Trueman D; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Wali N; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Williamson SC; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Moss J; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Montaudon E; Institut Curie, Paris, France., Derrien H; Institut Curie, Paris, France., Marangoni E; Institut Curie, Paris, France., Miragaia RJ; Oncology Data Science, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Gagrica S; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Morentin-Gutierrez P; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Moss TA; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Maglennon G; Clinical Pharmacology and Safety Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Sutton D; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Polanski R; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Rosen A; Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Cairns J; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Zhang P; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Sánchez-Guixé M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Critchlow SE; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Scott JS; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Lindemann JPO; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Barry ST; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Klinowska T; Late Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Morrow CJ; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Carnevalli LS; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.
Publikováno v:
Cancer research [Cancer Res] 2023 Dec 01; Vol. 83 (23), pp. 3989-4004.
Autor:
Hopcroft L; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Wigmore EM; Early Data Science, Oncology Data Science, AstraZeneca, Cambridge, UK., Williamson SC; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Ros S; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Eberlein C; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Moss JI; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Urosevic J; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Carnevalli LS; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Talbot S; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Bradshaw L; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Blaker C; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Gunda S; Information Technology, AstraZeneca, Chennai, Tamil Nadu, India., Owenson V; Imaging Sciences, AstraZeneca, Cambridge, UK., Hoffmann S; Imaging Sciences, AstraZeneca, Cambridge, UK., Sutton D; Imaging Sciences, AstraZeneca, Cambridge, UK., Jones S; Imaging Sciences, AstraZeneca, Cambridge, UK., Goodwin RJA; Imaging Sciences, AstraZeneca, Cambridge, UK., Willis BS; Bioscience Early Oncology, AstraZeneca, Boston, MA, USA., Rooney C; Translational Medicine, AstraZeneca, Cambridge, UK., de Bruin EC; Translational Medicine, AstraZeneca, Cambridge, UK., Barry ST; Bioscience Early Oncology, AstraZeneca, Cambridge, UK. Simon.T.Barry@astrazeneca.com.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2023 Sep 19; Vol. 9 (1), pp. 76. Date of Electronic Publication: 2023 Sep 19.
Autor:
Ramkumar K; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tanimoto A; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Della Corte CM; Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy., Stewart CA; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang Q; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shen L; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Cardnell RJ; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Polanska UM; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Andersen C; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Saeh J; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Pease JE; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Travers J; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Fabbri G; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Gay CM; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Urosevic J; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Byers LA; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Aug 15; Vol. 29 (16), pp. 3237-3249.
Autor:
Hopcroft L; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Wigmore EM; Early Data Science, Oncology Data Science, AstraZeneca, Cambridge, UK., Williamson SC; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Ros S; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Eberlein C; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Moss JI; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Urosevic J; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Carnevalli LS; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Talbot S; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Bradshaw L; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Blaker C; Bioscience Early Oncology, AstraZeneca, Cambridge, UK., Gunda S; Information Technology, AstraZeneca, Chennai, India., Owenson V; Imaging Sciences, AstraZeneca, Cambridge, UK., Hoffmann S; Imaging Sciences, AstraZeneca, Cambridge, UK., Sutton D; Imaging Sciences, AstraZeneca, Cambridge, UK., Jones S; Imaging Sciences, AstraZeneca, Cambridge, UK., Goodwin RJA; Imaging Sciences, AstraZeneca, Cambridge, UK., Willis BS; Bioscience Early Oncology, AstraZeneca, Boston, USA., Rooney C; Translational Medicine, AstraZeneca, Cambridge, UK., de Bruin EC; Translational Medicine, AstraZeneca, Cambridge, UK., Barry ST; Bioscience Early Oncology, AstraZeneca, Cambridge, UK. Simon.T.Barry@astrazeneca.com.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2023 Aug 05; Vol. 9 (1), pp. 64. Date of Electronic Publication: 2023 Aug 05.
Autor:
Bertran-Alamillo J; Laboratory of Oncology, Pangaea Oncology, Quiron Dexeus University Hospital, C/ Sabino Arana 5-19, 08913, Barcelona, Spain., Giménez-Capitán A; Laboratory of Oncology, Pangaea Oncology, Quiron Dexeus University Hospital, C/ Sabino Arana 5-19, 08913, Barcelona, Spain., Román R; Laboratory of Oncology, Pangaea Oncology, Quiron Dexeus University Hospital, C/ Sabino Arana 5-19, 08913, Barcelona, Spain., Talbot S; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Whiteley R; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Floc'h N; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Martínez-Pérez E; Bioinformatics Unit, Fundación Instituto Leloir, Buenos Aires, C1405BWE, Argentina., Martin MJ; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Smith PD; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Sullivan I; Servicio de Oncología Médica, Hospital de la Santa Creu i Sant Pau, Barcelona, 08025, Spain.; Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Barcelona, 08028, Spain., Terp MG; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense C, 5000, Denmark., Saeh J; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA, 02451, USA., Marino-Buslje C; Bioinformatics Unit, Fundación Instituto Leloir, Buenos Aires, C1405BWE, Argentina., Fabbri G; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA, 02451, USA., Guo G; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA, 02451, USA., Xu M; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA, 02451, USA., Tornador C; Teresa Moretó Foundation and Wholegenix SL, Barcelona, 08021, Spain., Aguilar-Hernández A; Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Barcelona, 08028, Spain., Reguart N; Thoracic Oncology Unit, Department of Medical Oncology, Hospital Clínic, Barcelona, 08036, Spain., Ditzel HJ; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense C, 5000, Denmark.; Department of Oncology, Odense University Hospital, Odense, 5000, Denmark., Martínez-Bueno A; Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Barcelona, 08028, Spain., Nabau-Moretó N; Teresa Moretó Foundation and Wholegenix SL, Barcelona, 08021, Spain., Gascó A; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Rosell R; Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Barcelona, 08028, Spain.; Germans Trias i Pujol Research Institute (IGTP), Badalona, 08916, Spain., Pease JE; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Polanska UM; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Travers J; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Urosevic J; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK. jelena.urosevic@astrazeneca.com., Molina-Vila MA; Laboratory of Oncology, Pangaea Oncology, Quiron Dexeus University Hospital, C/ Sabino Arana 5-19, 08913, Barcelona, Spain. mamolina@panoncology.com.
Publikováno v:
Molecular cancer [Mol Cancer] 2023 Jul 13; Vol. 22 (1), pp. 110. Date of Electronic Publication: 2023 Jul 13.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Criscione SW; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA. Steven.Criscione@astrazeneca.com., Martin MJ; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Oien DB; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Gorthi A; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA.; Department of Cell Systems & Anatomy, Greehey Children's Cancer Research Institute, University of Texas at Health San Antonio, San Antonio, TX, USA., Miragaia RJ; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Zhang J; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Chen H; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Karl DL; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Mendler K; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Markovets A; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Gagrica S; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Delpuech O; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Dry JR; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Grondine M; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Hattersley MM; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Urosevic J; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Floc'h N; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Drew L; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Yao Y; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA. yiyao1147@gmail.com., Smith PD; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK. Paul.D.Smith@astrazeneca.com.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2022 Dec 27; Vol. 6 (1), pp. 95. Date of Electronic Publication: 2022 Dec 27.